M.Pneumoniae P116
目录号 : GP23858Mycoplasma Pneumoniae P116 Recombinant
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
| Purity | Greater than 95% as determined by 12% PAGE (Coomassie staining). | Source | E.Coli |
| Phycical Appearance | Streile filtered colorless solution. | Shipping Condition | Shipped with Ice Packs. |
| Stability | Upon arrival, Store at -20°C .Please prevent freeze-thaw cycles. | ||
| Formulation | Mycoplasma Pneumoniae P116 is formulated in 1xPBS and 25mM arginine. | ||
Mycoplasma pneumonia is part of the atypical pneumonia subtype which is caused by the bacteria M. pneumoniae. Mycoplasma pneumonia affects individuals younger than 40. It makes up 15 - 50% of all pneumonia cases in adults and especially in school-aged children. People at great risk for mycoplasma pneumonia comprise of those living or working in busy areas such as schools and homeless shelters, although many people who contract mycoplasma pneumonia have no identifiable risk factor. P1, P30, and P116 of mycoplasma pneumonia membrane proteins have been recognized as adhensive factors, P1 is considered as a main adhension protein of the organism colonization.
The recombinant fusion protein was purified by GSH affinity chromatography technique.
Can be used forlateral flow product, ELISA assay and vaccine development.
Upon arrival, Store at -20°C .Please prevent freeze-thaw cycles.